- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
强势上涨过程中，可逢低买进，暂不考虑做空。
- 中期趋势：
有加速上涨趋势。
- 长期趋势：
已有34家主力机构披露2025-06-30报告期持股数据，持仓量总计2.45亿股，占流通A股27.22%
- 波段诊断：
-
技术面诊股
诊断结果：5.0技术面打败了17%的股票
技术面评分前10的股票
近期的平均成本为10.16元。多头行情中，并且有加速上涨趋势。
平均成本
近期的平均成本为10.16元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"10.16","date":1762245655,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势明显跑输大盘，明显跑输行业平均水平。
[{"date":"2025.11.05","stock":"0.20","trade":"0.13","ind":"0.23"},{"date":"2025.11.04","stock":"-1.07","trade":"-1.91","ind":"-0.41"},{"date":"2025.11.03","stock":"2.30","trade":"0.77","ind":"0.55"},{"date":"2025.10.31","stock":"1.21","trade":"3.64","ind":"-0.81"},{"date":"2025.10.30","stock":"-1.00","trade":"-1.21","ind":"-0.73"},{"date":"2025.10.29","stock":"-0.20","trade":"0.27","ind":"0.70"},{"date":"2025.10.28","stock":"-1.28","trade":"-0.37","ind":"-0.22"},{"date":"2025.10.27","stock":"0.30","trade":"0.79","ind":"1.18"},{"date":"2025.10.24","stock":"-0.88","trade":"-0.38","ind":"0.71"},{"date":"2025.10.23","stock":"-2.67","trade":"-1.12","ind":"0.22"},{"date":"2025.10.22","stock":"1.25","trade":"0.67","ind":"-0.07"},{"date":"2025.10.21","stock":"2.98","trade":"1.33","ind":"1.36"},{"date":"2025.10.20","stock":"0.70","trade":"0.37","ind":"0.63"},{"date":"2025.10.17","stock":"1.22","trade":"-1.01","ind":"-1.95"},{"date":"2025.10.16","stock":"-1.00","trade":"0.19","ind":"0.10"},{"date":"2025.10.15","stock":"0.40","trade":"2.81","ind":"1.22"},{"date":"2025.10.14","stock":"0.91","trade":"-1.22","ind":"-0.62"},{"date":"2025.10.13","stock":"-0.51","trade":"-0.84","ind":"-0.19"},{"date":"2025.10.10","stock":"1.23","trade":"-0.24","ind":"-0.94"},{"date":"2025.10.09","stock":"0.41","trade":"-0.39","ind":"1.32"},{"date":"2025.09.30","stock":"0.10","trade":"0.72","ind":"0.52"}]
鲁抗医药,上证指数,化学制药指数
压力支撑
该股压力位为10.12元，支撑位为10.03元。
[{"text":"\u538b\u529b\u4f4d","value":"10.12","date":1762272000,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"10.03","date":1762272000,"color":"0x0b52a1"}]
多空趋势
多头行情中，并且有加速上涨趋势。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：4.5资金面打败了83%的股票
主力控盘前10的股票
行业资金
化学制药行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：11月05日 17:29
| 机构今日流向(万元) | -906.76 | 机构5日流向(万元) | -2512.33 |
| 机构10日流向(万元) | -9026.95 | 机构20日流向(万元) | -18767.83 |
机构持仓
2025-06-30 与 2024-12-31 相比，主力机构持仓量增加728.03万股，其中基金数没有增加，主力净增仓10家，有一定的中长期投资价值。
截止2025-06-30，共34家主力机构（基金30家，一般法人4家），持仓量总计24458.99万股，占流通A股27.22%
其中，基金持仓与2024-12-31相比：
增仓：1家 ，增持 0.10万股
减仓：1家 ，减持 18.82万股
新出现在主力名单中：28家 ，持有1692.92万股
从主力名单中消失：18家 ，原持有444.95万股
其中，基金持仓与2024-12-31相比：
增仓：1家 ，增持 0.10万股
减仓：1家 ，减持 18.82万股
新出现在主力名单中：28家 ，持有1692.92万股
从主力名单中消失：18家 ，原持有444.95万股
消息面诊股
诊断结果：5.3消息面打败了60%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 鲁抗医药：11月4日获融资买入5136.37万元
2025-11-05 - 鲁抗医药：11月3日获融资买入9217.48万元
2025-11-04 - 鲁抗医药连续2日融资买入额增长率超50%，多头加速
2025-11-04 - 鲁抗医药前三季度营业收入46.24亿元，同比下降0
2025-11-03 - 鲁抗医药：10月31日获融资买入4982.49万元
2025-11-01 - 鲁抗医药：10月30日获融资买入2764.64万元
2025-10-31 - 股东追踪|张文忠等新进鲁抗医药前十大流通股东
2025-10-31 - 财报速递：鲁抗医药2025年前三季度净利润1.41
2025-11-01 - 鲁抗医药：第三季度净利润3436.12万元，同比下
2025-10-30 - 鲁抗医药：10月29日获融资买入3113.31万元
2025-10-30
消息列表
| 一般消息 | 高管变动 | 取消监事会 | 2025-10-10 |
| 一般消息 | 募资投向 | 公司出售资产 | 2025-09-26 |
| 一般消息 | 股东大会 | 临时股东大会 | 2025-09-20 |
| 一般消息 | 募资投向 | 公司购买资产 | 2025-09-20 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-08-28 |
| 一般消息 | 募资投向 | 公司购买资产 | 2025-08-28 |
| 一般消息 | 重大事项 | 关联交易 | 2025-08-21 |
| 重大利空 | 业绩预告 | 业绩大幅下降 | 2025-07-15 |
| 利好 | 分红转增 | 10派1.12元(含税) | 2025-03-22 |
| 一般消息 | 重大事项 | 关联交易 | 2025-03-22 |
| 重大利好 | 业绩预告 | 业绩大幅上升 | 2025-01-27 |
| 一般消息 | 重大事项 | 关联交易 | 2024-12-21 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 2条 | 1条 | 1条 |
| 利空 | 1条 | 1条 | 0条 |
行业面诊股
诊断结果：6.3行业面打败了75%的股票
化学制药行业最新资金流向
近10日来该行业走势不明显，跑输大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势不明显，跑输大盘。
[{"date":"2025.11.05","price":"0.23","value":"0.13"},{"date":"2025.11.04","price":"-0.41","value":"-1.91"},{"date":"2025.11.03","price":"0.55","value":"0.77"},{"date":"2025.10.31","price":"-0.81","value":"3.64"},{"date":"2025.10.30","price":"-0.73","value":"-1.21"},{"date":"2025.10.29","price":"0.70","value":"0.27"},{"date":"2025.10.28","price":"-0.22","value":"-0.37"},{"date":"2025.10.27","price":"1.18","value":"0.79"},{"date":"2025.10.24","price":"0.71","value":"-0.38"},{"date":"2025.10.23","price":"0.22","value":"-1.12"},{"date":"2025.10.22","price":"-0.07","value":"0.67"},{"date":"2025.10.21","price":"1.36","value":"1.33"},{"date":"2025.10.20","price":"0.63","value":"0.37"},{"date":"2025.10.17","price":"-1.95","value":"-1.01"},{"date":"2025.10.16","price":"0.10","value":"0.19"},{"date":"2025.10.15","price":"1.22","value":"2.81"},{"date":"2025.10.14","price":"-0.62","value":"-1.22"},{"date":"2025.10.13","price":"-0.19","value":"-0.84"},{"date":"2025.10.10","price":"-0.94","value":"-0.24"},{"date":"2025.10.09","price":"1.32","value":"-0.39"},{"date":"2025.09.30","price":"0.52","value":"0.72"}]
上证指数,化学制药行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 亚太药业 | 52.97% | 20.69% | 5.9分 |
| 2 | 多瑞医药 | 32.77% | -1.68% | 4.8分 |
| 3 | *ST景峰 | 32.42% | 1.17% | 5.7分 |
| 4 | 宏源药业 | 32.15% | 8.38% | 5.7分 |
| 5 | 康芝药业 | 31.61% | 16.60% | 6.3分 |
| 6 | 金石亚药 | 23.07% | 8.39% | 5.7分 |
| 8 | ST复华 | 20.93% | 17.29% | 5.1分 |
| 10 | 向日葵 | 19.48% | 0.33% | 5.2分 |
| 12 | 兴齐眼药 | 16.46% | -6.66% | 6.0分 |
| 14 | 海南海药 | 14.36% | 5.89% | 6.3分 |
| 16 | 莱美药业 | 11.68% | 4.82% | 6.0分 |
| 18 | 哈三联 | 10.72% | 2.91% | 4.8分 |
| 20 | 誉衡药业 | 10.36% | 2.10% | 6.8分 |
| 22 | 罗欣药业 | 9.02% | 3.42% | 5.5分 |
| 24 | 富祥药业 | 8.22% | 7.36% | 5.9分 |
| 26 | 华邦健康 | 7.91% | -0.81% | 5.3分 |
| 28 | - | 7.69% | 4.02% | 分 |
| 30 | 津药药业 | 7.43% | 3.09% | 6.1分 |
| 32 | 广生堂 | 7.37% | -6.00% | 4.3分 |
| 34 | 汉商集团 | 7.05% | 3.73% | 6.2分 |
| 36 | 尔康制药 | 6.51% | 2.86% | 5.9分 |
| 38 | - | 6.33% | -0.43% | 分 |
| 40 | 舒泰神 | 6.20% | 9.81% | 5.2分 |
| 42 | 山河药辅 | 5.89% | -1.51% | 4.5分 |
| 44 | 海正药业 | 5.48% | -0.54% | 6.3分 |
| 46 | 东北制药 | 5.44% | 1.63% | 5.5分 |
| 48 | 通化金马 | 5.20% | 5.57% | 5.8分 |
| 50 | 双鹭药业 | 5.00% | 1.20% | 5.3分 |
| 52 | 海欣股份 | 4.88% | 1.78% | 5.7分 |
| 54 | 威尔药业 | 4.78% | 3.87% | 6.2分 |
| 56 | 美诺华 | 4.74% | -0.61% | 4.9分 |
| 58 | - | 4.68% | 6.28% | 分 |
| 60 | 莎普爱思 | 4.64% | 0.87% | 5.2分 |
| 62 | 鲁抗医药 | 4.42% | 1.60% | 5.2分 |
| 64 | 灵康药业 | 3.66% | 2.90% | 5.1分 |
| 66 | 哈药股份 | 3.64% | 1.37% | 5.6分 |
| 68 | 华润双鹤 | 3.55% | 0.26% | 6.4分 |
| 70 | 拓新药业 | 3.22% | 3.51% | 4.5分 |
| 72 | 仟源医药 | 3.02% | -2.24% | 4.9分 |
| 74 | 立方制药 | 3.00% | 3.77% | 6.7分 |
| 76 | 新华制药 | 2.71% | 1.34% | 5.3分 |
| 78 | *ST三圣 | 2.33% | 0.21% | 3.3分 |
| 80 | 浙江医药 | 2.19% | -0.82% | 5.8分 |
| 82 | 共同药业 | 1.85% | 2.26% | 5.4分 |
| 84 | 新和成 | 1.57% | -1.23% | 6.7分 |
| 86 | 本立科技 | 1.49% | 1.31% | 5.1分 |
| 88 | 天新药业 | 1.19% | 1.07% | 5.2分 |
| 90 | 千红制药 | 0.89% | 2.13% | 5.7分 |
| 92 | - | -0.05% | -2.31% | 分 |
| 94 | 翰宇药业 | -0.19% | -4.49% | 5.3分 |
| 96 | 宣泰医药 | -0.46% | 0.46% | 5.0分 |
| 98 | 能特科技 | -0.79% | -2.58% | 5.3分 |
| 100 | 汇宇制药 | -1.30% | 3.32% | 5.3分 |
| 102 | 福元医药 | -1.61% | -0.09% | 5.5分 |
| 104 | 奥翔药业 | -2.16% | -1.58% | 4.9分 |
| 106 | *ST赛隆 | -2.33% | 3.44% | 5.7分 |
| 108 | 永安药业 | -2.49% | 2.38% | 4.5分 |
| 110 | 百利天恒 | -2.69% | 6.26% | 5.6分 |
| 112 | 司太立 | -2.75% | -3.02% | 4.7分 |
| 114 | 国邦医药 | -2.94% | -2.42% | 4.9分 |
| 116 | 北大医药 | -3.11% | -4.05% | 5.6分 |
| 118 | 花园生物 | -3.61% | -2.01% | 5.5分 |
| 120 | 卫信康 | -4.28% | -5.09% | 5.0分 |
| 122 | 圣诺生物 | -4.42% | -0.76% | 5.6分 |
| 124 | 微芯生物 | -4.96% | 4.70% | 5.4分 |
| 126 | 金城医药 | -5.81% | 2.70% | 5.7分 |
| 128 | 悦康药业 | -7.18% | -0.96% | 5.1分 |
| 130 | 博瑞医药 | -7.47% | 1.54% | 5.5分 |
| 132 | 亿帆医药 | -7.79% | -2.96% | 4.9分 |
| 134 | 科伦药业 | -7.87% | -2.74% | 5.4分 |
| 136 | 上海谊众 | -8.05% | -3.30% | 4.8分 |
| 138 | 奥赛康 | -8.10% | 3.08% | 5.3分 |
| 140 | 艾力斯 | -8.39% | -8.18% | 5.1分 |
| 142 | 诚意药业 | -8.96% | -1.91% | 4.6分 |
| 144 | 恩华药业 | -11.21% | -1.91% | 4.9分 |
| 146 | 百济神州 | -11.93% | -6.54% | 4.5分 |
| 148 | 京新药业 | -12.60% | -0.06% | 5.3分 |
| 150 | 华海药业 | -13.12% | -2.70% | 5.1分 |
| 152 | 恒瑞医药 | -13.40% | -3.22% | 5.3分 |
| 154 | 贝达药业 | -17.36% | -4.23% | 4.7分 |
| 156 | 盟科药业 | -21.08% | -3.23% | 4.9分 |
| 158 | 必贝特 | - | 6.31% | 3.5分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2025-09-30 ]公司经营
盈利能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 78/219 ， 129/219。
[{"date":"2025-09-30","value":"3.59","vol":"1.45"},{"date":"2025-06-30","value":"2.72","vol":"1.21"},{"date":"2025-03-31","value":"1.99","vol":"-0.17"},{"date":"2024-12-31","value":"10.48","vol":"19.51"},{"date":"2024-09-30","value":"9.25","vol":"4.61"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
3.59 | 2.72 | 1.99 | 10.48 | 9.25 |
| 行业(%) | 1.45 | 1.21 | -0.17 | 19.51 | 4.61 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"21.71","vol":"49.21"},{"date":"2025-06-30","value":"22.49","vol":"49.43"},{"date":"2025-03-31","value":"20.70","vol":"49.23"},{"date":"2024-12-31","value":"23.96","vol":"50.77"},{"date":"2024-09-30","value":"21.82","vol":"50.51"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
21.71 | 22.49 | 20.70 | 23.96 | 21.82 |
| 行业(%) | 49.21 | 49.43 | 49.23 | 50.77 | 50.51 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 65/219 ， 119/219。
[{"date":"2025-09-30","value":"-0.91","vol":"142.42"},{"date":"2025-06-30","value":"-3.83","vol":"78.53"},{"date":"2025-03-31","value":"-6.95","vol":"-0.84"},{"date":"2024-12-31","value":"1.41","vol":"17.76"},{"date":"2024-09-30","value":"-1.37","vol":"45.69"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-0.91 | -3.83 | -6.95 | 1.41 | -1.37 |
| 行业(%) | 142.42 | 78.53 | -0.84 | 17.76 | 45.69 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"-59.32","vol":"-6.13"},{"date":"2025-06-30","value":"-64.38","vol":"56.29"},{"date":"2025-03-31","value":"16.77","vol":"-21.21"},{"date":"2024-12-31","value":"60.30","vol":"-20.55"},{"date":"2024-09-30","value":"80.24","vol":"-32.33"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-59.32 | -64.38 | 16.77 | 60.30 | 80.24 |
| 行业(%) | -6.13 | 56.29 | -21.21 | -20.55 | -32.33 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 14/219 ， 32/219。
[{"date":"2025-09-30","value":"0.52","vol":"0.30"},{"date":"2025-06-30","value":"0.35","vol":"0.21"},{"date":"2025-03-31","value":"0.18","vol":"0.10"},{"date":"2024-12-31","value":"0.70","vol":"0.43"},{"date":"2024-09-30","value":"0.52","vol":"0.33"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.52 | 0.35 | 0.18 | 0.70 | 0.52 |
| 行业(次) | 0.30 | 0.21 | 0.10 | 0.43 | 0.33 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"2.63","vol":"1.96"},{"date":"2025-06-30","value":"1.78","vol":"1.31"},{"date":"2025-03-31","value":"0.93","vol":"0.67"},{"date":"2024-12-31","value":"3.28","vol":"3.22"},{"date":"2024-09-30","value":"2.68","vol":"2.18"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
2.63 | 1.78 | 0.93 | 3.28 | 2.68 |
| 行业(次) | 1.96 | 1.31 | 0.67 | 3.22 | 2.18 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2025-09-30","value":"-0.43","vol":"4.21"},{"date":"2025-06-30","value":"19.28","vol":"2.81"},{"date":"2025-03-31","value":"1.61","vol":"-28.76"},{"date":"2024-12-31","value":"-0.12","vol":"-371.46"},{"date":"2024-09-30","value":"15.93","vol":"-9.87"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | -0.43 | 19.28 | 1.61 | -0.12 | 15.93 |
| 行业 | 4.21 | 2.81 | -28.76 | -371.46 | -9.87 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"0.63","vol":"1.72"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"0.69","vol":"1.99"},{"date":"2024-09-30","value":"","vol":"0.00"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 0.63 | - | 0.69 | - |
| 行业 | 0.00 | 1.72 | 0.00 | 1.99 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 62/219 ， 26/219。
[{"date":"2025-09-30","value":"1.20","vol":"3.50"},{"date":"2025-06-30","value":"1.25","vol":"3.67"},{"date":"2025-03-31","value":"1.28","vol":"3.59"},{"date":"2024-12-31","value":"1.35","vol":"3.34"},{"date":"2024-09-30","value":"1.20","vol":"3.66"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 流动比率 |
1.20 | 1.25 | 1.28 | 1.35 | 1.20 |
| 行业 | 3.50 | 3.67 | 3.59 | 3.34 | 3.66 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"0.77","vol":"2.74"},{"date":"2025-06-30","value":"0.82","vol":"2.89"},{"date":"2025-03-31","value":"0.83","vol":"2.81"},{"date":"2024-12-31","value":"0.84","vol":"2.64"},{"date":"2024-09-30","value":"0.80","vol":"2.92"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 速动比率 |
0.77 | 0.82 | 0.83 | 0.84 | 0.80 |
| 行业 | 2.74 | 2.89 | 2.81 | 2.64 | 2.92 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 14/219 ， 24/219。
[{"date":"2025-09-30","value":"53.44","vol":"33.67"},{"date":"2025-06-30","value":"53.96","vol":"33.79"},{"date":"2025-03-31","value":"54.65","vol":"34.04"},{"date":"2024-12-31","value":"55.36","vol":"34.19"},{"date":"2024-09-30","value":"55.92","vol":"33.02"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
53.44 | 53.96 | 54.65 | 55.36 | 55.92 |
| 行业(%) | 33.67 | 33.79 | 34.04 | 34.19 | 33.02 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"1.19","vol":"0.94"},{"date":"2025-06-30","value":"1.22","vol":"0.88"},{"date":"2025-03-31","value":"1.25","vol":"1.46"},{"date":"2024-12-31","value":"1.29","vol":"0.84"},{"date":"2024-09-30","value":"1.31","vol":"0.73"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
1.19 | 1.22 | 1.25 | 1.29 | 1.31 |
| 行业(%) | 0.94 | 0.88 | 1.46 | 0.84 | 0.73 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
暂时还没有机构预测该股2025年的收益，请投资者后续关注。
[{"date":"2021","yellowRectValue":"0.83","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"1.38","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"2.46","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"3.95","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]